Guardant Health's Shield test gains EviCore coverage in 2027

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Guardant Health's Shield test gains EviCore coverage in 2027

Guardant Health’s Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening

September 14, 2026 4:05 PM EDT

Second largest national medical benefit manager in the U.S. expands coverage for FDA-approved Shield blood test for colorectal cancer (CRC) screening to eligible policyholders Milestone marks rapid adoption by insurers for the most clinically-validated blood test for CRC Increasing total covered Shield lives ages 45 and older to approximately 94 million, representing the overwhelming majority of eligible patients in the U.S.

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for... More